Intravenous iron therapy
Othereach patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses
NCT Number: NCT03157050
the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.
Looking for future studies?
Notify Me19 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses
Time frame: on day 0 of start of intravenous iron and 1 week after completion of intravenous iron
change in patient health questionnaire-9 score before and after intravenous iron therapy
Benha University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06844890
Behavior, Behavioral Symptoms
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05090397
Behavior, Behavioral Symptoms
Chicago, Illinois, United States
View Trial DetailsNCT07760701
Anxiety, Anxiety Disorders
Lusaka, Lusaka Province, Zambia
View Trial DetailsNCT05804838
Behavior, Behavioral Symptoms
Istanbul, Umraniye, Turkey (Türkiye)
View Trial Details